Buthiazide
- Molecular formula
- C15H21NO3
- CAS Number
- 146-09-8
- IUPAC Name
- 2-(4-butoxy-3-methyl-phenyl)ethanehydroxamic acid
- Molecular Weight
- 285.37g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.1200g/cm3
- Synonyms
- 2-(4-Butoxy-m-tolyl)acetohydroxamic acid
Identification
Interesting Facts about 2-(4-butoxy-3-methyl-phenyl)ethanehydroxamic acid
2-(4-butoxy-3-methyl-phenyl)ethanehydroxamic acid is a fascinating compound that intersects various fields of chemistry, especially in the areas of medicinal and synthetic chemistry. Here are some intriguing aspects of this compound:
- Versatile Applications: This compound has potential applications in drug development, particularly as a hydroxamic acid derivative, which is known to possess anti-cancer properties.
- Structure-Activity Relationship: The unique structure provides opportunities for modifying its chemical properties to enhance efficacy and reduce toxicity, making it a key candidate for synthesis studies.
- Hydroxamic Acids: Compounds like this one, with hydroxamic acid functional groups, are notable for their ability to chelate metal ions. This property is important in various biological processes and industrial applications.
- Researchers' Interest: Scientists are continually exploring the various reactions and pathways involving hydroxamic acids, which can lead to the discovery of new pharmacological agents.
As noted by a leading researcher in the field, "The exploration of derivatives of hydroxamic acids opens up new avenues in targeted therapy, providing a versatile tool in the fight against cancer." This statement emphasizes the importance of structural modifications in enhancing the compound's therapeutic potential.
In summary, 2-(4-butoxy-3-methyl-phenyl)ethanehydroxamic acid not only has intriguing properties on its own but also serves as a gateway to innovative research and development in medical chemistry. Its synthesis, modification, and application may yield significant contributions to the future of pharmacotherapy.